Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Hospital, Caen
Region Stockholm
Beth Israel Deaconess Medical Center
Massachusetts General Hospital
Assistance Publique Hopitaux De Marseille
Nordsjaellands Hospital
Weill Medical College of Cornell University
Centre Hospitalier Universitaire, Amiens
Janssen Research & Development, LLC
Rambam Health Care Campus
Janssen Scientific Affairs, LLC
University Medical Center Groningen
University of Saskatchewan
Hospital Galdakao-Usansolo
Centre Hospitalier Universitaire de Saint Etienne
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Alliance Foundation Trials, LLC.
Université de Sherbrooke
Radboud University Medical Center
OMNI Medical Services, LLC
University of Alabama at Birmingham
Assistance Publique - Hôpitaux de Paris
AstraZeneca
AstraZeneca
Cedars-Sinai Medical Center
Charite University, Berlin, Germany
Charite University, Berlin, Germany
Leiden University Medical Center
Charite University, Berlin, Germany
Portsmouth Hospitals NHS Trust
The Cleveland Clinic
Karolinska University Hospital
AbbVie
Novadaq Technologies ULC, now a part of Stryker
UCB Pharma
UCB Pharma
Evangelisches Krankenhaus Düsseldorf
Ohio State University Comprehensive Cancer Center
Beijing Friendship Hospital
Janssen Research & Development, LLC
National Institutes of Health Clinical Center (CC)
Radboud University Medical Center
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Novartis
FDA Office of Orphan Products Development
University Hospitals Cleveland Medical Center
Atlanta VA Medical Center
Mayo Clinic
French Society of Coloproctology